The US Food and Drug Administration (FDA) has approved Roche’s Tecentriq or atezolizumab as adjuvant treatment for patients with Stage II-IIIA non-small cell lung cancer (NSCLC) whose tumors express PD-L1=1%, as determined…
Tag: Treatment of Lung Cancer
Lung Cancer Treatment May Impact Daily Function in Elderly Patients
According to the new research published in Journal of the American Geriatrics Society, older adults with lung cancer may experience decline in life-space mobility during lung cancer treatment. The study has been…
Study Finds New Possibilities for Lung Cancer Treatment in ‘Never Smokers’
Smoking is the well-known reason for causing lung cancer among a significant amount of people. But, there are also those lung cancer patients who have never smoked in their life but still…
Robotic Surgery for Lung Cancer: What You Need to Know
In today’s article, we are taking a close look at robotic surgery for lung cancer. Robotic lung surgery was introduced back in 2002 and the technique is called as RATS which is…
Takeda’s Exkivity Approved by FDA for Rare form of Lung Cancer
Takeda Pharmaceutical Co. Ltd. becomes the first one to get FDA approval for an oral drug targeted against rare form of non-small cell lung cancer. FDA has approved Exkivity (mobocertinib) for treatment…
Study: Stem-Like T Cells May Help Immunotherapy in Lung Cancer Treatment
In a new study conducted by the Yale Cancer Center, the researchers have found that stem-like T cells in certain lymph nodes may be natural cancer fighters. The findings have been reported…
Study Suggests Biomarker May Help in Predicting Benefits of Immunotherapy
Immunotherapy is a widely used method for treatment of several types of cancers including lung cancer, bladder cancer and more. Immune-based treatments for cancers have raised hope of doctors as well as…
Chemotherapy and Immunotherapy Combination to Provide Effective Lung Cancer Treatment
According to a study published in Science Translational Medicine, a combination of two cancer treatments could provide effective treatment for lung cancer by targeting immune cells involved with formulation of tumors. The…